Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Three-dose vs extended-course clindamycin prophylaxis for free-flap reconstruction of the head and neck ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY Carroll, W. R., Rosenstiel, D., Fix, J. R., de la Torre, J., Solomon, J. S., Brodish, B., Rosenthal, E. L., Heinz, T., Niwas, S., Peters, G. E. 2003; 129 (7): 771-774

Abstract

Twenty-four hours of perioperative antibiotics provides effective prophylaxis for most head and neck cancer resections. Many reconstructive surgeons have been hesitant to apply this standard to free-flap reconstruction of the head and neck. This prospective clinical trial compared short-course and long-course clindamycin prophylaxis for wound infection in patients with head and neck cancer undergoing free-flap reconstruction.Seventy-four patients were randomized to receive short-course (3 doses) or long-course (15 doses) clindamycin perioperatively. Wound infections, fistulas, and other postoperative complications were documented by faculty surgeons who were blinded as to treatment group.The differences in wound infections and other complications were statistically insignificant. No other independent predictors of wound complications emerged in this series of patients.Short-course clindamycin is as effective as long-course clindamycin in preventing wound infections after free-flap surgery for head and neck ablative defects.

View details for Web of Science ID 000184104400015

View details for PubMedID 12874080